SynthesisBMC musculoskeletal disorders2025
Total hip arthroplasty in hip tuberculosis: a systematic review.
Synthesis in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Misdiagnosis of tuberculous infection as pseudo-bursa cyst after total hip arthroplasty: a case report.Frontiers in surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTuberculosis of the hip joint is a common form of bone tuberculosis that can cause severe joint destruction and affect quality of life. Total hip arthroplasty (THA) is an important way to treat hip joint-related diseases. In recent years, THA has been applied to treat tuberculosis of the hip joint and has achieved certain results. To this end, we conducted a systematic review of total hip arthroplasty (THA) for the treatment of tuberculosis of the hip.
methodsWe searched six electronic databases, including the CNKI Database, Wanfang Database, PubMed, Web of Science, Embase, and Cochrane Library, to systematically review and evaluate the literature on hip replacement in patients with acute tuberculative coxitis from the establishment of the database until July 2024. The results of the analysis included patient demographic characteristics, clinical presentation, antituberculosis therapy and surgical protocols, and surgical outcomes. A meta-analysis was performed if the data were available.
resultsAmong a total of 1843 articles, 38 studies were selected, of which 24 studies reported relevant data for meta-analysis. A total of 855 patients (mean age: 34 to 57 years, mean follow-up: 0.5 to 11 years) were enrolled. In general, physicians are accustomed to deciding the appropriate timing of surgery based on inflammatory markers; 90% of the studies recommended preoperative and postoperative antituberculosis therapy (ATT), and 14 studies used antituberculosis drugs during surgery. The majority of the studies used single-stage surgery, and 6 studies used two-stage surgery; cemented prostheses were used in 19.6% of the surgeries, cementless prostheses were used in 79.5% of the surgeries, and hybrid fixation was used in 0.9% of the surgeries. The lateral and posterior approaches were dominant in the included studies. In all the studies, 34 patients experienced disease reactivation. The average complication(defective healing, followed by aseptic loosening, dislocation, deep venous thrombosis, and so on) rate was 11.2%(39/300 cases). The mean Harris hip score (HHS) at the final follow-up was 89.05.
conclusionTHA is an effective method for treating tubercular arthritis of the hip. In the past, it was thought to increase the risk of disease reactivation, but studies have shown generally favorable results, THA could significantly improve patients' quality of life. Two-stage surgery can be used in complex patients at greater risk. A long course of multidrug antituberculosis therapy is crucial for preventing reactivation and enhancing the effectiveness of surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.